R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

New HIV variant highlights the importance of monitoring viru...

Researchers discovered a highly virulent variant of HIV in the Netherlands that genetic sequence analysis suggests has been circulating since the 1990s.

R&D

Why was R&D productivity up in 2021?

A recent report has found that R&D productivity rose vertiginously during 2021, but how much of this was organic and how much can be attributed to the pandemic?

Oncology

Cancer vaccines: providing the edge in oncology

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector.

R&D

Importance of diversity in pharma and clinical trials

“Diversity.” It’s a word that is very commonly thrown around right now, not just in pharma and healthcare but across all industries.

R&D

How NINR project is solidifying UK’s remote trial know how

Assumptions to evidence: How NIHR project is solidifying UK’...

Remote, virtual, or decentralised clinical trials are nothing new, but COVID-19 catapulted the model into the mainstream.

Digital

Digital innovation drives vaccine development

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovatio